Clinical Trials Details

NRG-GI005 COBRA (Colon)

A Phase II/III Study of Circulating tumOr DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)